| __timestamp | Lantheus Holdings, Inc. | Vericel Corporation |
|---|---|---|
| Wednesday, January 1, 2014 | 72429000 | 13774000 |
| Thursday, January 1, 2015 | 78634000 | 22479000 |
| Friday, January 1, 2016 | 75374000 | 27388000 |
| Sunday, January 1, 2017 | 92157000 | 35610000 |
| Monday, January 1, 2018 | 93326000 | 49007000 |
| Tuesday, January 1, 2019 | 103132000 | 61139000 |
| Wednesday, January 1, 2020 | 110171000 | 68836000 |
| Friday, January 1, 2021 | 218817000 | 97592000 |
| Saturday, January 1, 2022 | 233827000 | 106903000 |
| Sunday, January 1, 2023 | 267194000 | 120998000 |
Infusing magic into the data realm
In the competitive landscape of the healthcare sector, understanding the financial strategies of key players is crucial. This analysis delves into the Selling, General, and Administrative (SG&A) expenses of Lantheus Holdings, Inc. and Vericel Corporation from 2014 to 2023. Over this period, Lantheus Holdings has seen a remarkable increase in SG&A expenses, growing by approximately 270%, from $72 million in 2014 to $267 million in 2023. This suggests a strategic investment in operational capabilities and market expansion. In contrast, Vericel Corporation's SG&A expenses have surged by nearly 780%, from $14 million to $121 million, indicating aggressive growth and scaling efforts. These trends highlight the dynamic nature of financial management in the healthcare industry, where companies must balance cost control with strategic investments to maintain competitive advantage.
Who Optimizes SG&A Costs Better? Merck & Co., Inc. or Lantheus Holdings, Inc.
Amgen Inc. vs Vericel Corporation: SG&A Expense Trends
Regeneron Pharmaceuticals, Inc. and Vericel Corporation: SG&A Spending Patterns Compared
Breaking Down SG&A Expenses: United Therapeutics Corporation vs Lantheus Holdings, Inc.
United Therapeutics Corporation vs Vericel Corporation: SG&A Expense Trends
Operational Costs Compared: SG&A Analysis of Summit Therapeutics Inc. and Vericel Corporation
Cost Management Insights: SG&A Expenses for Insmed Incorporated and Vericel Corporation
Selling, General, and Administrative Costs: Lantheus Holdings, Inc. vs Cytokinetics, Incorporated
Cost Management Insights: SG&A Expenses for Lantheus Holdings, Inc. and Corcept Therapeutics Incorporated
Selling, General, and Administrative Costs: Lantheus Holdings, Inc. vs PTC Therapeutics, Inc.
Cost Management Insights: SG&A Expenses for Lantheus Holdings, Inc. and Perrigo Company plc
Comparing SG&A Expenses: Lantheus Holdings, Inc. vs Celldex Therapeutics, Inc. Trends and Insights